# CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial

> **NCT07652528** · NA · NOT_YET_RECRUITING · sponsor: **Hallym University** · enrollment: 50 (estimated)

## Conditions studied

- Sudden Sensorineural Hearing Loss (SSNHL)
- Prediabetes / Type 2 Diabetes

## Interventions

- **DEVICE:** CareLevo Patch-type Insulin Pump
- **DRUG:** Insulin Glargine U-100 (Lantus)
- **DRUG:** Fast-acting Insulin Aspart (Fiasp)
- **DEVICE:** CareSens Air Continuous Glucose Monitor

## Key facts

- **NCT ID:** NCT07652528
- **Lead sponsor:** Hallym University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-06
- **Final completion:** 2028-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652528, "CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*